0001209191-12-042654.txt : 20120820
0001209191-12-042654.hdr.sgml : 20120818
20120820172025
ACCESSION NUMBER: 0001209191-12-042654
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120816
FILED AS OF DATE: 20120820
DATE AS OF CHANGE: 20120820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Lisa
CENTRAL INDEX KEY: 0001349077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 121046020
MAIL ADDRESS:
STREET 1: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2012-08-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001349077
Kelly Lisa
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2012-08-16
4
M
0
953
32.16
A
18202
D
Common Stock
2012-08-16
4
S
0
953
55.00
D
17249
D
Common Stock
1957
I
401(k)
Employee Stock Option (right to buy)
32.16
2012-08-16
4
M
0
953
0.00
D
2018-07-23
Common Stock
953
954
D
Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Fully vested.
Omar White, Attorney-In-Fact
2012-08-20